Skip to main content

Table 1 Baseline characteristics of all participants, and across the three groups: OSA with CPAP, OSA without CPAP, and non-OSA

From: Obstructive sleep apnoea and 12-month weight loss in adults with class 3 obesity attending a multidisciplinary weight management program

Variable
Mean±SD or n(%)
OSA (n=70) Non-OSA (n=41) p value*
OSA with CPAP (n=38) OSA without CPAP (n=32)
Age (years) 57.0 ± 12.4 53.5 ± 10.9 50.6 ± 14.7 0.100
Female 22 (57.9 %) 20 (62.5 %) 37 (90.2 %) 0.003
Caucasian 24 (63.2 %) 23 (71.9 %) 33 (80.5 %) 0.230
Not in paid employment 27 (71.1 %) 17 (53.1 %) 20 (48.8 %) 0.112
Weight (kg) 148.1 ± 31.3 140.4 ± 26.6 134.9 ± 29.2 0.137
BMI (kg/m2) 52.1 ± 8.7 50.3 ± 9.5 50.4 ± 9.3 0.636
Hypertension 28 (73.7 %) 23 (71.9 %) 24 (58.5 %) 0.294
T2DM 26 (68.4 %) 20 (62.5 %) 23 (56.1 %) 0.528
Dyslipidaemia 28 (73.7 %) 25 (78.1 %) 25 (61.0 %) 0.240
Cardiovascular disease 9 (23.7 %) 6 (18.8 %) 5 (12.2 %) 0.441
Non-Alcoholic Fatty liver disease (NAFLD) 5 (13.2 %) 7 (21.9 %) 6 (14.6 %) 0.579
Gastro-oesophageal Reflux Disease (GORD) 13 (34.2 %) 20 (62.5 %) 18 (43.9 %) 0.039
Total Cholesterol (mmol/L) 4.5 ± 1.1 4.4 ± 0.9 4.4 ± 1.2 0.880
Triglycerides (mmol/L) 1.9 ± 1.5 1.8 ± 0.8 1.8 ± 0.8 0.845
LDL Cholesterol (mmol/L) 2.5 ± 1.0 2.5 ± 0.7 2.4 ± 1.2 0.925
HDL Cholesterol (mmol/L) 1.1 ± 0.3 1.1 ± 0.3 1.2 ± 0.3 0.642
ALT (IU/L) 33.4 ± 23.5 27.8 ± 13.4 30.2 ± 14.5 0.447
Epworth Sleepiness Scale score 7.7 ± 5.3 8.5 ± 4.8 5.8 ± 5.1 0.078
Berlin Score 2.5 ± 0.7 2.4 ± 0.7 2.3 ± 0.7 0.532
  1. *p-values reflects the difference across three groups.